| Literature DB >> 20945055 |
J Storim1, J Stoevesandt, D Anders, H Kneitz, E-B Bröcker, A Trautmann.
Abstract
Chelation therapy with (RS)-2,3-Bis(sulfonyl)propane-1-sulfonic acid (DMPS) after an occupational lead exposure led to the development of a severe bullous drug eruption. Skin tests and histology/immunohistology of the test reactions indicated a T-cell-mediated immune response against DMPS. Metal-binding thiol groups as in DMPS are chemically highly reactive and therefore effectively mediate the development of immunogenic hapten (DMPS)-protein complexes. Therefore, the pharmacological effects and sensitization potential of dithiols are tightly connected. Cross-reactivity of DMPS to other chelators like D-penicillamine is possible; the indications for chelation therapy should be weighed carefully.Entities:
Mesh:
Substances:
Year: 2011 PMID: 20945055 DOI: 10.1007/s00105-010-1993-9
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751